根據NASDAQ TVTX報道，Travere Therapeutics 公司報告了季度每股虧損 $-0.47，這一數據比分析師普遍預測的 $-0.56 高出 16.07%。相比去年同期每股虧損 $-0.94，有50%的上漲。公司季度銷售額爲 $7479萬，比分析師普遍預測的 $7334萬 高出 1.98%。相比去年同期的 $4506萬，銷售額增長了 65.98%。

以上內容來自Benzinga Earnings專欄，原文如下：

Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.56) by 16.07 percent. This is a 50 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $74.79 million which beat the analyst consensus estimate of $73.34 million by 1.98 percent. This is a 65.98 percent increase over sales of $45.06 million the same period last year.